Press Releases

13/05 Merck : Q1 26 Financial Statement PU
13/05 Merck : Q1 26 Press Release PU
13/05 Merck : Q1 26 Summary PU
13/05 Merck : Darmstadt, Germany, Delivers Solid Start to the Year and Upgrades Full-Year Guidance PU
13/05 Merck : Strategic Update May 13, 2026 PU
05/05 Merck : Darmstadt, Germany, Opens €20 million Metrology and Inspection Site in France for Global Chip Industry PU
30/04 Merck : Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations PU
24/04 Merck : (AGM 2026 Presence and Voting Results NA) PU
24/04 Merck : (AGM 2026 Dividend Announcement NA) PU
24/04 Merck : (AGM 2026 GOR Dividend EN NA) PU
24/04 AGM: Beckmann to be appointed as CEO May 1 PU
25/03 Merck KGaA: Freifrau Helene Röder von Diersburg, buy EQ
25/03 Merck KGaA: Belén Garijo Lopez, buy EQ
14/03 Merck : Prospectus - C-032386 PU
12/03 Merck : (AGM 2026 Explanation Shareholder Rights EN NA) PU
05/03 Merck : ESG Presentation PU
05/03 Merck : Q4 25 Earnings Presentation PU
05/03 Merck : Q4 25 Financial Statement PU
05/03 Merck : Q4 25 Summary PU
05/03 Merck KGaA, Darmstadt, Germany: Guidance for 2025 Delivered, Growth Foundation in Place PU
29/01 Merck : Benjamin Hein Appointed as Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO of Electronics PU
26/01 Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements EQ
13/01 Merck : FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor PU
22/12 Merck : Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor PU
16/12 Merck : Darmstadt, Germany, Launches ChemiSphere® App to Simplify Digital Data Access and Boost Lab Efficiency PU
No results for this search